NCT03617536 - A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus | Biotech Hunter

Enrollment

269

Participants

Timeline

Start Date

July 5, 2018

Primary Completion Date

October 24, 2019

Study Completion Date

November 14, 2019

Conditions

Chronic Kidney DiseasesPruritus

Interventions

DRUG

CR845 0.25 mg Oral Tablet

CR845 0.25 mg medication taken orally 1 time/day

DRUG

CR845 0.5 mg Oral Tablet

CR845 0.5 mg medication taken orally 1 time/day

DRUG

CR845 1 mg Oral Tablet

CR845 1 mg medication taken orally 1 time/day

DRUG

Placebo Oral Tablet

Placebo tablet taken orally 1 time/day

Trial Locations (60)

11229

Cara Therapeutics Study Site, Brooklyn

11501

Cara Therapeutics Study Site, Mineola

17011

Cara Therapeutics Study Site, Camp Hill

20037

Cara Therapeutics Study Site, Washington D.C.

20912

Cara Therapeutics Study Site, Takoma Park

21287

Cara Therapeutics Study Site, Baltimore

22304

Cara Therapeutics Study Site, Alexandria

27804

Cara Therapeutics Study Site, Rocky Mount

29605

Cara Therapeutics Study Site, Greenville

30328

Cara Therapeutics Study Site, Sandy Springs

30909

Cara Therapeutics Study Site, Augusta

32132

Cara Therapeutics Study Site, Edgewater

32810

Cara Therapeutics Study Site, Orlando

33016

Cara Therapeutics Study Site, Hialeah

33024

Cara Therapeutics Study Site, Hollywood

33125

Cara Therapeutics Study Site 1, Miami

33155

Cara Therapeutics Study Site 2, Miami

33467

Cara Therapeutics Study Site, Lake Worth

33614

Cara Therapeutics Study Site, Tampa

33637

Cara Therapeutics Study Site, Temple Terrace

34471

Cara Therapeutics Study Site, Ocala

35233

Cara Therapeutics Study Site, Birmingham

35630

Cara Therapeutics Study Site, Florence

43215

Cara Therapeutics Study Site, Columbus

48066

Cara Therapeutics Study Site, Roseville

48081

Cara Therapeutics Study Site, Saint Clair

48503

Cara Therapeutics Study Site, Flint

48532

Cara Therapeutics Study Site 2, Flint

52242

Cara Therapeutics Study Site, Iowa City

57702

Cara Therapeutics Study Site, Rapid City

60012

Cara Therapeutics Study Site, Crystal Lake

60201

Cara Therapeutics Study Site, Evanston

64111

Cara Therapeutics Study Site, Kansas City

70006

Cara Therapeutics Study Site, Metairie

70115

Cara Therapeutics Study Site, New Orleans

70791

Cara Therapeutics Study Site, Zachary

72432

Cara Therapeutics Study Site, Harrisburg

73071

Cara Therapeutics Study Site, Norman

75093

Cara Therapeutics Study Site, Plano

75110

Cara Therapeutics Study Site, Corsicana

77074

Cara Therapeutics Study Site, Houston

77081

Cara Therapeutics Study Site, Houston

78207

Cara Therapeutics Study Site, San Antonio

78224

Cara Therapeutics Study Site, San Antonio

78629

Cara Therapeutics Study Site, Gonzales

80230

Cara Therapeutics Study Site, Denver

85016

Cara Therapeutics Study Site, Phoenix

85351

Cara Therapeutics Study Site, Sun City

86401

Cara Therapeutics Study Site, Prescott

90602

Cara Therapeutics Study Site, Whittier

90717

Cara Therapeutics Study Site, Lomita

91324

Cara Therapeutics Study Site, Northridge

91351

Cara Therapeutics Study Site, Canyon Country

92025

Cara Therapeutics Study Site, Escondido

92505

Cara Therapeutics Study Site, Riverside

93309

Cara Therapeutics Study Site, Bakersfield

95831

Cara Therapeutics Study Site, Sacramento

99309

Cara Therapeutics Study Site 2, Bakersfield

02903

Cara Therapeutics Study Site, Providence

02886

Cara Therapeutics Study Site, Warwick